Infant Bacterial Therapeutics AB Announces Distribution Agreement For Israeli Market

Infant Bacterial Therapeutics AB announced on 3/5/19 the first distribution agreement for IBP-9414 with Megapharm Ltd. for the Israeli market and the Palestinian Authority’s territories. The agreement gives MegaPharm exclusive rights to market and sell the product, if and when the product receives market approval, after the pivotal clinical phase III trial that is expected to start during the current half year.